SURROZEN, INC.
Profile
Company Names
SURROZEN, INC.
Addresses
171 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
510-703-9491
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$49,999,991.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-06-04
$49,999,991.00
$50,000,000.00
$9.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
GOEDDEL
DIRECTOR
IGENICA INC
| NGM BIOPHARMACEUTICALS INC
| CONSTELLATION PHARMACEUTICALS INC
| PELOTON THERAPEUTICS, INC.
| NURIX, INC.
| NEURONA THERAPEUTICS INC
| IGENICA BIOTHERAPEUTICS, INC
| FLX BIO, INC.
| EXONICS THERAPEUTICS, INC.
| SURROZEN, INC.
| A2 BIOTHERAPEUTICS, INC.
| HEXAGON BIO INC.
| COLUMN GROUP V, LP
| COLUMN GROUP OPPORTUNITY III, LP
| COLUMN GROUP SPV I, LP
| NGM BIO HOLDINGS, INC.
TIM
KUTZKEY
DIRECTOR
CARMOT THERAPEUTICS INC.
| CYTERIX PHARMACEUTICALS INC.
| PELOTON THERAPEUTICS, INC.
| NEURONA THERAPEUTICS INC
| KALLYOPE, INC.
| COLUMN GROUP III-A, LP
| COLUMN GROUP III, LP
| SURROZEN, INC.
| NEURONA THERAPEUTICS, INC
| COLUMN GROUP V, LP
| COLUMN GROUP OPPORTUNITY III, LP
| COLUMN GROUP SPV I, LP
| COLUMN GROUP-NEURO II, LP
| SITE TX, INC.
| NILO THERAPEUTICS, INC.
| NGM BIO HOLDINGS, INC.
CRAIG
PARKER
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
